| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |